Compendium of Cancer Genome Aberrations

FEMA5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
Newer edit →
VisualWikitext
Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo..."
 
No edit summary
Line 17: Line 17:
!'''Notes'''
!'''Notes'''
|-
|-
|[[FEMA5:Serous_cystadenoma,_adenofibroma,_and_surface_papilloma_of_the_ovary|Serous cystadenoma, adenofibroma, and surface papilloma of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Serous_borderline_tumour_of_the_ovary|Serous borderline tumour of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Low-grade_serous_carcinoma_of_the_ovary|Low-grade serous carcinoma of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:High-grade_serous_carcinoma_of_the_ovary|High-grade serous carcinoma of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[FEMA5:Mucinous_cystadenoma_and_adenofibroma|Mucinous cystadenoma and adenofibroma]]
|Disease
|
|
|
|
|
Line 27: Line 72:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Mucinous_borderline_tumour_|Mucinous borderline tumour]]
|Disease
|
|
|
|
|
Line 36: Line 83:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Mucinous_carcinoma_of_the_ovary|Mucinous carcinoma of the ovary]]
|Disease
|
|
|
|
|
Line 45: Line 94:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Endometrioid_cystadenoma_and_adenofibroma|Endometrioid cystadenoma and adenofibroma]]
|Disease
|
|
|
|
|
Line 54: Line 105:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Endometrioid_borderline_tumour|Endometrioid borderline tumour]]
|Disease
|
|
|
|
|
Line 63: Line 116:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Endometrioid_carcinoma_of_the_ovary|Endometrioid carcinoma of the ovary]]
|Disease
|
|
|
|
|
Line 72: Line 127:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Clear_cell_cystadenoma_and_adenofibroma|Clear cell cystadenoma and adenofibroma]]
|Disease
|
|
|
|
|
Line 81: Line 138:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Clear_cell_borderline_tumour|Clear cell borderline tumour]]
|Disease
|
|
|
|
|
Line 90: Line 149:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Clear_cell_carcinoma_of_the_ovary|Clear cell carcinoma of the ovary]]
|Disease
|
|
|
|
|
Line 99: Line 160:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Seromucinous_cystadenoma_and_adenofibroma|Seromucinous cystadenoma and adenofibroma]]
|Disease
|
|
|
|
|
Line 108: Line 171:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Seromucinous_borderline_tumour|Seromucinous borderline tumour]]
|Disease
|
|
|
|
|
Line 117: Line 182:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Brenner_tumour_|Brenner tumour]]
|Disease
|
|
|
|
|
Line 126: Line 193:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Borderline_Brenner_tumour|Borderline Brenner tumour]]
|Disease
|
|
|
|
|
Line 135: Line 204:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Malignant_Brenner_tumour_|Malignant Brenner tumour]]
|Disease
|
|
|
|
|
Line 144: Line 215:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Mesonephric-like_adenocarcinoma|Mesonephric-like adenocarcinoma]]
|Disease
|
|
|
|
|
Line 153: Line 226:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Undifferentiated_and_dedifferentiated_carcinomas_of_the_ovary|Undifferentiated and dedifferentiated carcinomas of the ovary]]
|Disease
|
|
|
|
|
Line 162: Line 237:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Carcinosarcoma_of_the_ovary|Carcinosarcoma of the ovary]]
|Disease
|
|
|
|
|
Line 171: Line 248:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Mixed_carcinoma_of_the_ovary|Mixed carcinoma of the ovary]]
|Disease
|
|
|
|
|
Line 180: Line 259:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Endometrioid_stromal_sarcoma_of_the_ovary|Endometrioid stromal sarcoma of the ovary]]
|Disease
|
|
|
|
|
Line 189: Line 270:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Smooth_muscle_tumours_of_the_ovary|Smooth muscle tumours of the ovary]]
|Disease
|
|
|
|
|
Line 198: Line 281:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Ovarian_myxoma_|Ovarian myxoma]]
|Disease
|
|
|
|
|
Line 207: Line 292:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Adenosarcoma_of_the_ovary|Adenosarcoma of the ovary]]
|Disease
|
|
|
|
|
Line 216: Line 303:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Ovarian_fibroma_|Ovarian fibroma]]
|Disease
|
|
|
|
|
Line 225: Line 314:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Thecoma_|Thecoma]]
|Disease
|
|
|
|
|
Line 234: Line 325:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Luteinized_thecoma_associated_with_sclerosing_peritonitis_|Luteinized thecoma associated with sclerosing peritonitis]]
|Disease
|
|
|
|
|
Line 243: Line 336:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Sclerosing_stromal_tumour_|Sclerosing stromal tumour]]
|Disease
|
|
|
|
|
Line 252: Line 347:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Microcystic_stromal_tumour_|Microcystic stromal tumour]]
|Disease
|
|
|
|
|
Line 261: Line 358:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Signet-ring_stromal_tumour_|Signet-ring stromal tumour]]
|Disease
|
|
|
|
|
Line 270: Line 369:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Leydig_cell_tumour_|Leydig cell tumour]]
|Disease
|
|
|
|
|
Line 279: Line 380:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Steroid_cell_tumour_|Steroid cell tumour]]
|Disease
|
|
|
|
|
Line 288: Line 391:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Ovarian_fibrosarcoma_|Ovarian fibrosarcoma]]
|Disease
|
|
|
|
|
Line 297: Line 402:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Adult_granulosa_cell_tumour_|Adult granulosa cell tumour]]
|Disease
|
|
|
|
|
Line 306: Line 413:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Juvenile_granulosa_cell_tumour_|Juvenile granulosa cell tumour]]
|Disease
|
|
|
|
|
Line 315: Line 424:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Sertoli_cell_tumour_|Sertoli cell tumour]]
|Disease
|
|
|
|
|
Line 324: Line 435:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Sex_cord_tumour_with_annular_tubules_|Sex cord tumour with annular tubules]]
|Disease
|
|
|
|
|
Line 333: Line 446:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Sertoli-Leydig_cell_tumour|Sertoli-Leydig cell tumour]]
|Disease
|
|
|
|
|
Line 342: Line 457:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Sex_cord-stromal_tumour_NOS|Sex cord-stromal tumour NOS]]
|Disease
|
|
|
|
|
Line 351: Line 468:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Gynandroblastoma|Gynandroblastoma]]
|Disease
|
|
|
|
|
Line 360: Line 479:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Mature_teratoma_of_the_ovary|Mature teratoma of the ovary]]
|Disease
|
|
|
|
|
Line 369: Line 490:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Immature_teratoma_of_the_ovary|Immature teratoma of the ovary]]
|Disease
|
|
|
|
|
Line 378: Line 501:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Dysgerminoma_|Dysgerminoma]]
|Disease
|
|
|
|
|
Line 387: Line 512:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Yolk_sac_tumour_|Yolk sac tumour]]
|Disease
|
|
|
|
|
Line 396: Line 523:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Embryonal_carcinoma_|Embryonal carcinoma]]
|Disease
|
|
|
|
|
Line 405: Line 534:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Non-gestational_choriocarcinoma_|Non-gestational choriocarcinoma]]
|Disease
|
|
|
|
|
Line 414: Line 545:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Mixed_germ_cell_tumour_of_the_ovary|Mixed germ cell tumour of the ovary]]
|Disease
|
|
|
|
|
Line 423: Line 556:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Struma_ovarii_|Struma ovarii]]
|Disease
|
|
|
|
|
Line 432: Line 567:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Ovarian_carcinoid|Ovarian carcinoid]]
|Disease
|
|
|
|
|
Line 441: Line 578:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Neuroectodermal-type_tumours|Neuroectodermal-type tumours]]
|Disease
|
|
|
|
|
Line 450: Line 589:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Monodermal_cystic_teratoma_|Monodermal cystic teratoma]]
|Disease
|
|
|
|
|
Line 459: Line 600:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Somatic_neoplasms_arising_from_teratomas|Somatic neoplasms arising from teratomas]]
|Disease
|
|
|
|
|
Line 468: Line 611:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Gonadoblastoma|Gonadoblastoma]]
|Disease
|
|
|
|
|
Line 477: Line 622:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Mixed_germ_cell-sex_cord-stromal_tumour,_unclassified|Mixed germ cell-sex cord-stromal tumour, unclassified]]
|Disease
|
|
|
|
|
Line 486: Line 633:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Rete_cystadenoma,_adenoma,_and_adenocarcinoma|Rete cystadenoma, adenoma, and adenocarcinoma]]
|Disease
|
|
|
|
|
Line 495: Line 644:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Wolffian_tumour_of_the_ovary|Wolffian tumour of the ovary]]
|Disease
|
|
|
|
|
Line 504: Line 655:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Solid_pseudopapillary_tumour_|Solid pseudopapillary tumour]]
|Disease
|
|
|
|
|
Line 513: Line 666:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Small_cell_carcinoma_of_the_ovary,_hypercalcaemic_type|Small cell carcinoma of the ovary, hypercalcaemic type]]
|Disease
|
|
|
|
|
Line 522: Line 677:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Wilms_tumour_|Wilms tumour]]
|Disease
|
|
|
|
|
Line 531: Line 688:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Follicle_cyst|Follicle cyst]]
|Disease
|
|
|
|
|
Line 540: Line 699:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Corpus_luteum_cyst|Corpus luteum cyst]]
|Disease
|
|
|
|
|
Line 549: Line 710:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Large_solitary_luteinized_follicle_cyst|Large solitary luteinized follicle cyst]]
|Disease
|
|
|
|
|
Line 558: Line 721:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Hyperreactio_luteinalis|Hyperreactio luteinalis]]
|Disease
|
|
|
|
|
Line 567: Line 732:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Pregnancy_luteoma|Pregnancy luteoma]]
|Disease
|
|
|
|
|
Line 576: Line 743:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Stromal_hyperplasia_and_hyperthecosis|Stromal hyperplasia and hyperthecosis]]
|Disease
|
|
|
|
|
Line 585: Line 754:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Fibromatosis_and_massive_oedema|Fibromatosis and massive oedema]]
|Disease
|
|
|
|
|
Line 594: Line 765:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Leydig_cell_hyperplasia|Leydig cell hyperplasia]]
|Disease
|
|
|
|
|
Line 603: Line 776:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Metastases_to_the_ovary|Metastases to the ovary]]
|Disease
|
|
|
|
|
Line 612: Line 787:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Endometriosis_and_derived_tumours|Endometriosis and derived tumours]]
|Disease
|
|
|
|
|
Line 621: Line 798:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Adenomatoid_tumour_|Adenomatoid tumour]]
|Disease
|
|
|
|
|
Line 630: Line 809:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Well-differentiated_papillary_mesothelial_tumour_|Well-differentiated papillary mesothelial tumour]]
|Disease
|
|
|
|
|
Line 639: Line 820:
|
|
|-
|-
| ||Disease||
|[[FEMA5:_Mesothelioma_| Mesothelioma]]
|Disease
|
|
|
|
|
Line 648: Line 831:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Serous_borderline_tumour_of_the_peritoneum|Serous borderline tumour of the peritoneum]]
|Disease
|
|
|
|
|
Line 657: Line 842:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Low-grade_serous_carcinoma_of_the_peritoneum|Low-grade serous carcinoma of the peritoneum]]
|Disease
|
|
|
|
|
Line 666: Line 853:
|
|
|-
|-
| ||Disease||
|[[FEMA5:High-grade_serous_carcinoma_of_the_peritoneum|High-grade serous carcinoma of the peritoneum]]
|Disease
|
|
|
|
|
Line 675: Line 864:
|
|
|-
|-
| ||Disease||
|[[FEMA5:_Leiomyomatosis_peritonealis_disseminata_| Leiomyomatosis peritonealis disseminata]]
|Disease
|
|
|
|
|
Line 684: Line 875:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|Disease
|
|
|
|
|
Line 693: Line 886:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Calcifying_fibrous_tumour_|Calcifying fibrous tumour]]
|Disease
|
|
|
|
|
Line 702: Line 897:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Extragastrointestinal_stromal_tumour|Extragastrointestinal stromal tumour]]
|Disease
|
|
|
|
|
Line 711: Line 908:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Solitary_fibrous_tumour_of_the_peritoneum|Solitary fibrous tumour of the peritoneum]]
|Disease
|
|
|
|
|
Line 720: Line 919:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Endometrioid_stromal_sarcoma_of_the_peritoneum|Endometrioid stromal sarcoma of the peritoneum]]
|Disease
|
|
|
|
|
Line 729: Line 930:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|Disease
|
|
|
|
|
Line 738: Line 941:
|
|
|-
|-
|[[FEMA5:Mesothelial_hyperplasia|Mesothelial hyperplasia]]
|Disease
|
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Peritoneal_inclusion_cysts_|Peritoneal inclusion cysts]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Transitional_cell_metaplasia|Transitional cell metaplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endosalpingiosis_of_the_peritoneum|Endosalpingiosis of the peritoneum]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Histiocytic_nodule|Histiocytic nodule]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Ectopic_decidua|Ectopic decidua]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Splenosis|Splenosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Other_tumour-like_lesions_of_the_peritoneum|Other tumour-like lesions of the peritoneum]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Carcinomas_and_sarcomas_metastatic_to_the_peritoneum|Carcinomas and sarcomas metastatic to the peritoneum]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Pseudomyxoma_peritonei|Pseudomyxoma peritonei]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Gliomatosis|Gliomatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Serous_adenofibroma_and_papilloma_of_the_fallopian_tube|Serous adenofibroma and papilloma of the fallopian tube]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Serous_borderline_tumour_of_the_fallopian_tube|Serous borderline tumour of the fallopian tube]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:High-grade_serous_carcinoma_of_the_fallopian_tube|High-grade serous carcinoma of the fallopian tube]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endometrioid_carcinoma_of_the_fallopian_tube|Endometrioid carcinoma of the fallopian tube]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Carcinosarcoma_of_the_fallopian_tube|Carcinosarcoma of the fallopian tube]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Paratubal_cysts|Paratubal cysts]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Tubal_hyperplasia|Tubal hyperplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Tubo-ovarian_abscess|Tubo-ovarian abscess]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Salpingitis_isthmica_nodosa|Salpingitis isthmica nodosa]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Metaplastic_papillary_lesion|Metaplastic papillary lesion]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Placental_site_nodule_occurring_in_the_fallopian_tube|Placental site nodule occurring in the fallopian tube]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mucinous_metaplasia|Mucinous metaplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenosarcoma_of_the_fallopian_tube|Adenosarcoma of the fallopian tube]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Teratoma_of_the_fallopian_tube|Teratoma of the fallopian tube]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Leiomyoma_of_the_broad_ligament_and_other_uterine_ligaments|Leiomyoma of the broad ligament and other uterine ligaments]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenomyoma_of_the_broad_ligament_and_other_uterine_ligaments|Adenomyoma of the broad ligament and other uterine ligaments]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenosarcoma_of_the_broad_ligament_and_other_uterine_ligaments|Adenosarcoma of the broad ligament and other uterine ligaments]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Leiomyosarcoma_of_the_broad_ligament_and_other_uterine_ligaments|Leiomyosarcoma of the broad ligament and other uterine ligaments]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Wolffian_tumour_of_the_broad_ligament_and_other_uterine_ligaments|Wolffian tumour of the broad ligament and other uterine ligaments]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Papillary_cystadenoma_|Papillary cystadenoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Ependymoma_|Ependymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adrenocortical_remnants|Adrenocortical remnants]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endometrial_hyperplasia_without_atypia|Endometrial hyperplasia without atypia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endometrial_atypical_hyperplasia_/_endometrioid_intraepithelial_neoplasia|Endometrial atypical hyperplasia / endometrioid intraepithelial neoplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endometrioid_carcinoma_of_the_uterine_corpus|Endometrioid carcinoma of the uterine corpus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Serous_carcinoma_of_the_uterine_corpus|Serous carcinoma of the uterine corpus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Clear_cell_carcinoma_of_the_uterine_corpus_|Clear cell carcinoma of the uterine corpus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Undifferentiated_and_dedifferentiated_carcinomas_of_the_uterine_corpus|Undifferentiated and dedifferentiated carcinomas of the uterine corpus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mixed_carcinoma_of_the_uterine_corpus|Mixed carcinoma of the uterine corpus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Other_endometrial_carcinomas|Other endometrial carcinomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Carcinosarcoma_of_the_uterine_corpus|Carcinosarcoma of the uterine corpus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endometrial_polyp|Endometrial polyp]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endometrial_metaplasia|Endometrial metaplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Arias-Stella_reaction_of_the_uterine_corpus|Arias-Stella reaction of the uterine corpus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Uterine_leiomyoma|Uterine leiomyoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Intravenous_leiomyomatosis_|Intravenous leiomyomatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Smooth_muscle_tumour_of_uncertain_malignant_potential_of_the_uterine_corpus|Smooth muscle tumour of uncertain malignant potential of the uterine corpus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Metastasizing_leiomyoma_|Metastasizing leiomyoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Uterine_leiomyosarcoma_|Uterine leiomyosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endometrial_stromal_nodule_|Endometrial stromal nodule]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Low-grade_endometrial_stromal_sarcoma_|Low-grade endometrial stromal sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:High-grade_endometrial_stromal_sarcoma_|High-grade endometrial stromal sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Undifferentiated_uterine_sarcoma_|Undifferentiated uterine sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Uterine_tumour_resembling_ovarian_sex_cord_tumour_|Uterine tumour resembling ovarian sex cord tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Perivascular_epithelioid_cell_tumour_(PEComa)|Perivascular epithelioid cell tumour (PEComa)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenomyoma_of_the_uterine_corpus|Adenomyoma of the uterine corpus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Atypical_polypoid_adenomyoma_|Atypical polypoid adenomyoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenosarcoma_of_the_uterine_corpus|Adenosarcoma of the uterine corpus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Central_primitive_neuroectodermal_tumour_/_CNS_embryonal_tumour|Central primitive neuroectodermal tumour / CNS embryonal tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Germ_cell_tumours_of_the_uterine_corpus|Germ cell tumours of the uterine corpus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Exaggerated_placental_site_reaction|Exaggerated placental site reaction]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Placental_site_nodule_and_plaque|Placental site nodule and plaque]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Abnormal_(non-molar)_villous_lesions|Abnormal (non-molar) villous lesions]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Partial_hydatidiform_mole|Partial hydatidiform mole]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Complete_hydatidiform_mole|Complete hydatidiform mole]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Invasive_and_metastatic_hydatidiform_moles|Invasive and metastatic hydatidiform moles]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Epithelioid_trophoblastic_tumour_|Epithelioid trophoblastic tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Placental_site_trophoblastic_tumour_|Placental site trophoblastic tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Gestational_choriocarcinoma|Gestational choriocarcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mixed_trophoblastic_tumour|Mixed trophoblastic tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Squamous_metaplasia|Squamous metaplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Atrophy_of_the_uterine_cervix|Atrophy of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Squamous_intraepithelial_lesions_of_the_uterine_cervix|Squamous intraepithelial lesions of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Squamous_cell_carcinoma,_HPV-associated,_of_the_uterine_cervix|Squamous cell carcinoma, HPV-associated, of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Squamous_cell_carcinoma,_HPV-independent,_of_the_uterine_cervix|Squamous cell carcinoma, HPV-independent, of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endocervical_polyp|Endocervical polyp]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mullerian_papilloma_of_the_uterine_cervix|Mullerian papilloma of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Nabothian_cyst|Nabothian cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Tunnel_clusters|Tunnel clusters]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Microglandular_hyperplasia|Microglandular hyperplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Lobular_endocervical_glandular_hyperplasia|Lobular endocervical glandular hyperplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Diffuse_laminar_endocervical_hyperplasia|Diffuse laminar endocervical hyperplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mesonephric_remnants_and_hyperplasia|Mesonephric remnants and hyperplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Arias-Stella_reaction_of_the_uterine_cervix|Arias-Stella reaction of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endocervicosis_of_the_uterine_cervix|Endocervicosis of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Tuboendometrioid_metaplasia|Tuboendometrioid metaplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Ectopic_prostate_tissue|Ectopic prostate tissue]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenocarcinoma_in_situ,_HPV-associated,_of_the_uterine_cervix|Adenocarcinoma in situ, HPV-associated, of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenocarcinoma,_HPV-associated,_of_the_uterine_cervix|Adenocarcinoma, HPV-associated, of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenocarcinoma_in_situ,_HPV-independent,_of_the_uterine_cervix|Adenocarcinoma in situ, HPV-independent, of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenocarcinoma,_HPV-independent,_gastric_type,_of_the_uterine_cervix|Adenocarcinoma, HPV-independent, gastric type, of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenocarcinoma,_HPV-independent,_clear_cell_type,_of_the_uterine_cervix|Adenocarcinoma, HPV-independent, clear cell type, of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenocarcinoma,_HPV-independent,_mesonephric_type,_of_the_uterine_cervix|Adenocarcinoma, HPV-independent, mesonephric type, of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Other_adenocarcinomas_of_the_uterine_cervix|Other adenocarcinomas of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Carcinosarcoma_of_the_uterine_cervix|Carcinosarcoma of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenosquamous_and_mucoepidermoid_carcinomas_of_the_uterine_cervix|Adenosquamous and mucoepidermoid carcinomas of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenoid_basal_carcinoma_of_the_uterine_cervix|Adenoid basal carcinoma of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Carcinoma_of_the_uterine_cervix,_unclassifiable|Carcinoma of the uterine cervix, unclassifiable]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenomyoma_of_the_uterine_cervix|Adenomyoma of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenosarcoma_of_the_uterine_cervix|Adenosarcoma of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Germ_cell_tumours_of_the_uterine_cervix|Germ cell tumours of the uterine cervix]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Squamous_papilloma_of_the_vagina|Squamous papilloma of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Atrophy_of_the_vagina|Atrophy of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Tubulosquamous_polyp_|Tubulosquamous polyp]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Squamous_intraepithelial_lesions_of_the_vagina|Squamous intraepithelial lesions of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Squamous_cell_carcinoma,_HPV-associated,_of_the_vagina|Squamous cell carcinoma, HPV-associated, of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Squamous_cell_carcinoma,_HPV-independent,_of_the_vagina|Squamous cell carcinoma, HPV-independent, of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Villous_adenoma_|Villous adenoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mullerian_papilloma_of_the_vagina|Mullerian papilloma of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Vaginal_adenosis|Vaginal adenosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endocervicosis_of_the_vagina|Endocervicosis of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Cysts_of_the_vagina|Cysts of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenocarcinoma,_HPV-associated,_of_the_vagina|Adenocarcinoma, HPV-associated, of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endometrioid_carcinoma_of_the_vagina|Endometrioid carcinoma of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Clear_cell_carcinoma_of_the_vagina|Clear cell carcinoma of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mucinous_carcinoma,_gastric_type,_of_the_vagina|Mucinous carcinoma, gastric type, of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mucinous_carcinoma,_intestinal_type,_of_the_vagina|Mucinous carcinoma, intestinal type, of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mesonephric_adenocarcinoma_of_the_vagina|Mesonephric adenocarcinoma of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Carcinosarcoma_of_the_vagina|Carcinosarcoma of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mixed_tumour_of_the_vagina|Mixed tumour of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenocarcinoma_of_Skene_gland_origin_|Adenocarcinoma of Skene gland origin]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenosquamous_carcinoma_of_the_vagina|Adenosquamous carcinoma of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenosarcoma_of_the_vagina_|Adenosarcoma of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Germ_cell_tumours_of_the_vagina|Germ cell tumours of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Seborrhoeic_keratosis|Seborrhoeic keratosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Condyloma_acuminatum|Condyloma acuminatum]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Squamous_intraepithelial_lesions,_HPV-associated,_of_the_vulva|Squamous intraepithelial lesions, HPV-associated, of the vulva]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Vulvar_intraepithelial_neoplasia,_HPV-independent|Vulvar intraepithelial neoplasia, HPV-independent]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Squamous_cell_carcinoma,_HPV-associated,_of_the_vulva|Squamous cell carcinoma, HPV-associated, of the vulva]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Squamous_cell_carcinoma,_HPV-independent,_of_the_vulva|Squamous cell carcinoma, HPV-independent, of the vulva]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Papillary_hidradenoma_|Papillary hidradenoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Chondroid_syringoma|Chondroid syringoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Fibroadenoma_|Fibroadenoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Phyllodes_tumour|Phyllodes tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenocarcinoma_of_mammary_gland_type_|Adenocarcinoma of mammary gland type]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Bartholin_gland_cyst|Bartholin gland cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Bartholin_gland_hyperplasia,_adenoma,_and_adenomyoma|Bartholin gland hyperplasia, adenoma, and adenomyoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Bartholin_gland_carcinomas|Bartholin gland carcinomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Other_cysts_of_the_vulva|Other cysts of the vulva]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Paget_disease_|Paget disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Carcinomas_of_sweat_gland_origin|Carcinomas of sweat gland origin]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenocarcinoma_of_intestinal_type_|Adenocarcinoma of intestinal type]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Germ_cell_tumours_of_the_vulva|Germ cell tumours of the vulva]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Neuroendocrine_tumour|Neuroendocrine tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Carcinoma_admixed_with_neuroendocrine_carcinoma_|Carcinoma admixed with neuroendocrine carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Florid_reactive_lymphoid_hyperplasia|Florid reactive lymphoid hyperplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Extranodal_marginal_zone_lymphoma|Extranodal marginal zone lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Follicular_lymphoma|Follicular lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Burkitt_lymphoma|Burkitt lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Myeloid_sarcoma|Myeloid sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Lipoma_|Lipoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Lipoblastoma-like_tumour_of_the_vulva|Lipoblastoma-like tumour of the vulva]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Liposarcoma_|Liposarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Postoperative_spindle_cell_nodule|Postoperative spindle cell nodule]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Fibroepithelial_stromal_polyp|Fibroepithelial stromal polyp]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Prepubertal_fibroma|Prepubertal fibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Superficial_myofibroblastoma_|Superficial myofibroblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Myofibroblastoma_|Myofibroblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Cellular_angiofibroma_|Cellular angiofibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Angiomyofibroblastoma_|Angiomyofibroblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Solitary_fibrous_tumour_of_the_lower_genital_tract|Solitary fibrous tumour of the lower genital tract]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Dermatofibrosarcoma_protuberans_|Dermatofibrosarcoma protuberans]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Kaposi_sarcoma_|Kaposi sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Angiosarcoma_|Angiosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Leiomyoma_of_the_lower_genital_tract|Leiomyoma of the lower genital tract]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Smooth_muscle_tumour_of_uncertain_malignant_potential_of_the_lower_genital_tract|Smooth muscle tumour of uncertain malignant potential of the lower genital tract]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Leiomyosarcoma_of_the_lower_genital_tract|Leiomyosarcoma of the lower genital tract]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Rhabdomyoma_|Rhabdomyoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Benign_peripheral_nerve_sheath_tumours|Benign peripheral nerve sheath tumours]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Granular_cell_tumour_|Granular cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Superficial_angiomyxoma_|Superficial angiomyxoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Deep_(aggressive)_angiomyxoma_|Deep (aggressive) angiomyxoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Epithelioid_sarcoma_|Epithelioid sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Alveolar_soft_part_sarcoma_|Alveolar soft part sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Ewing_sarcoma_|Ewing sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Acquired_melanocytic_naevus|Acquired melanocytic naevus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Congenital_melanocytic_naevus_|Congenital melanocytic naevus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Blue_naevus_|Blue naevus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Atypical_melanocytic_naevus_of_genital_type_|Atypical melanocytic naevus of genital type]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Dysplastic_melanocytic_naevus_|Dysplastic melanocytic naevus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mucosal_melanoma_|Mucosal melanoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Metastasis_to_the_lower_female_genital_tract|Metastasis to the lower female genital tract]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Lynch_syndrome|Lynch syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Cowden_syndrome|Cowden syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Ataxia-telangiectasia|Ataxia-telangiectasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Carney_complex|Carney complex]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:DICER1_syndrome_|DICER1 syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Ovarian_dysgenesis|Ovarian dysgenesis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma|Hereditary leiomyomatosis and renal cell carcinoma]]
|Disease
|Disease
|
|
Retrieved from "https://test.ccga.io/index.php/FEMA5:Volunteer_Assignments_and_Opportunities"